TELA Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
TELA Bio Inc is not a good buy for a beginner investor with a long-term focus at this time. The stock is trading at a low price with bearish technical indicators, lack of positive catalysts, and reduced growth expectations. Analysts have significantly lowered price targets and growth guidance, and there is no recent news or influential trading activity to suggest a turnaround. The financial performance shows some revenue growth but declining net income and EPS, which does not align with a strong long-term investment opportunity.
The stock shows bearish technical indicators. The MACD is below 0 and negatively contracting, RSI is neutral at 37.452, and moving averages indicate a bearish trend (SMA_200 > SMA_20 > SMA_5). The stock is trading near its support level of 0.542, with resistance levels at 0.846 and 0.94.
The company's gross margin increased by 3.66% YoY in Q4 2025, indicating some operational efficiency improvements.
The company missed topline estimates in Q4 2025, and net income and EPS have declined YoY. There is no recent news or significant trading activity from hedge funds, insiders, or Congress to suggest a positive shift.
In Q4 2025, revenue increased by 18.24% YoY to $20,869,000. However, net income dropped by 1.81% YoY to -$9,041,000, and EPS declined by 26.09% YoY to -0.17. Gross margin improved to 65.91%, up 3.66% YoY.
Analysts have lowered price targets significantly, with targets ranging from $1 to $3, down from previous targets of $1.25 to $5. Ratings include Buy and Neutral, but analysts highlight lowered growth expectations and a 'show me' sentiment toward the stock.
